首页> 美国卫生研究院文献>Indian Journal of Clinical Biochemistry >A Study on the Level of T3 T4 TSH and the Association of A/G Polymorphism with CTLA-4 Gene in Graves’ Hyperthyroidism among South Indian Population
【2h】

A Study on the Level of T3 T4 TSH and the Association of A/G Polymorphism with CTLA-4 Gene in Graves’ Hyperthyroidism among South Indian Population

机译:南印度人格雷夫斯甲状腺功能亢进症中T3T4TSH水平以及A / G多态性与CTLA-4基因的关联研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Graves’ disease (GD) is an organ-specific heterogenous autoimmune disorder associated with T-lymphocyte abnormality affecting the thyroid, eyes and skin. GD is a multifactorial disease that develops as a result of complex interaction between genetic susceptibility genes and environmental factors. It has been suggested that the Cytotoxic T lymphocytes associated molecule-4 (CTLA-4) is a genetic susceptibility candidate for GD. The present study was focused on A/G polymorphism at position 49 in exon-1 of the CTLA-4 gene in 80 GD patients (GP) and 80 sex and age matched healthy individuals among South Indian (Madurai) population. Serum concentrations of thyroid hormone (T4, T3 and TSH) were determined by using automated analyzer. The genomic DNA was isolated from the patient and control groups and genotyping was performed using the polymerase chain reaction followed by restriction enzyme analysis using Bbv1. Significant difference (P < 0.001) was observed in the level of T3, T4 and TSH in GD patients and healthy individuals. The results revealed the CTLA-4 gene G/G genotype to be 32 (40%) in patients and 26 (32.50%) in healthy individuals, A/G genotype to be 37 (46.25%) in patients and 25 (31.25%) in healthy individuals and A/A genotype to be 11 (13.75%) in patients and 29 (36.25%) in healthy individuals. The calculated odds ratio (OR) in individuals with mutant genotype (GG/AG) reveal 3.6 fold risk for GD (95% confidence interval = 1.6–7.8). The mutant “G” allele frequency was observed to be 0.63 in GD patients and 0.48 in healthy individuals. Thus the present study demonstrates an association between the CTLA-4 gene polymorphism and Graves’ disease.
机译:格雷夫斯病(GD)是一种器官特异性异种自身免疫性疾病,与T淋巴细胞异常有关,影响甲状腺,眼睛和皮肤。 GD是一种多因素疾病,是由于遗传易感基因与环境因素之间复杂的相互作用所致。已经提出细胞毒性T淋巴细胞相关分子4(CTLA-4)是GD的遗传易感性候选物。本研究的重点是在南印度(Madurai)人群中的80名GD患者(GP)和80位性别和年龄匹配的健康个体中CTLA-4基因外显子1的49位A / G多态性。使用自动分析仪测定血清甲状腺激素(T4,T3和TSH)浓度。从患者和对照组中分离出基因组DNA,并使用聚合酶链反应进行基因分型,然后使用Bbv1进行限制性酶分析。在GD患者和健康个体中观察到T3,T4和TSH的水平存在显着差异(P <0.001)。结果显示,CTLA-4基因G / G基因型在患者中为32(40%),在健康个体中为26(32.50%),A / G基因型在患者中为37(46.25%),在患者中为25(31.25%)健康个体的A / A基因型为11(13.75%),健康个体为29(36.25%)。具有突变基因型(GG / AG)的个体的计算比值比(OR)显示GD的风险为3.6倍(95%置信区间= 1.6-7.8)。在GD患者中观察到突变的“ G”等位基因频率为0.63,在健康个体中为0.48。因此,本研究表明CTLA-4基因多态性与Graves病之间存在关联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号